Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IgA Levels Are Associated with Coronary Artery Lesions in Kawasaki Disease. | Korean Circ J | 2021 | 33655727 | PubTator, text mining | PubMed |
| Rosmarinic acid inhibits cell proliferation, migration, and invasion and induces apoptosis in human glioma cells. | Int J Mol Med | 2021 | 33649774 | PubTator, text mining | PubMed |
| ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. | Nat Genet | 2021 | 33633365 | PubTator, text mining | PubMed |
| Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application. | Cancer Sci | 2021 | 33605517 | PubTator, text mining | PubMed |
| Targeting critical kinases and anti-apoptotic molecules overcomes steroid resistance in MLL-rearranged leukaemia. | EBioMedicine | 2021 | 33581643 | PubTator, text mining | PubMed |
| The Application of Next Generation Sequencing Maturity Onset Diabetes of the Young Gene Panel in Turkish Patients from Trakya Region | J Clin Res Pediatr Endocrinol | 2021 | 33565752 | PubTator, text mining | PubMed |
| The Ins and Outs of RAS Effector Complexes. | Biomolecules | 2021 | 33562401 | PubTator, text mining | PubMed |
| Antineoplastic kinase inhibitors: A new class of potent anti-amoebic compounds. | PLoS Negl Trop Dis | 2021 | 33556060 | PubTator, text mining | PubMed |
| Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension. | Int J Mol Sci | 2021 | 33540939 | PubTator, text mining | PubMed |
| Tumor microenvironment characterization in triple-negative breast cancer identifies prognostic gene signature. | Aging (Albany NY) | 2021 | 33536349 | PubTator, text mining | PubMed |
| Identification of hub genes and key pathways in the emphysema phenotype of COPD. | Aging (Albany NY) | 2021 | 33535173 | PubTator, text mining | PubMed |
KMU-1170, a Novel Multi-Protein Kinase Inhibitor, Suppresses Inflammatory Signal Transduction in THP-1 Cells and Human Osteoarthritic Fibroblast-Like Synoviocytes by Suppressing Activation of NF-κB and NLRP3 Inflammasome Signaling Pathway. | Int J Mol Sci | 2021 | 33530480 | PubTator, text mining | PubMed |
| A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma. | Oncoimmunology | 2021 | 33520406 | PubTator, text mining | PubMed |
| FSS-2019-nCov: A deep learning architecture for semi-supervised few-shot segmentation of COVID-19 infection. | Knowl Based Syst | 2021 | 33519100 | PubTator, text mining | PubMed |
| Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases. | CNS Drugs | 2021 | 33515429 | PubTator, text mining | PubMed |
| A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma. | Dis Markers | 2021 | 33510822 | PubTator, text mining | PubMed |
| Development of a potent and selective chemical probe for the pleiotropic kinase CK2. | Cell Chem Biol | 2021 | 33484635 | PubTator, text mining | PubMed |
| The Mutation Spectrum of Maturity Onset Diabetes of the Young (MODY)-Associated Genes among Western Siberia Patients. | J Pers Med | 2021 | 33477506 | PubTator, text mining | PubMed |
| Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases. | Cell Mol Life Sci | 2021 | 33449144 | PubTator, text mining | PubMed |
| Hyperinsulinism in an individual with an EP300 variant of Rubinstein-Taybi syndrome. | Am J Med Genet A | 2021 | 33442921 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=42